Award
BPA Call #36C24126N0961
Continuation Call for ThyroSeq Molecular Testing Services with Cytopath Biopsy Lab
Buyer
Department of Veterans Affairs
Award Amount
$45,000.00
Ceiling
$45,000.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2027
Identifier
36C24126N0961
NAICS
621511
This award represents a definitive blanket purchase agreement (BPA) call under a long-term multi-year contract with Cytopath Biopsy Lab Inc., a specialized laboratory focused on advanced molecular diagnostic biopsy services. The contract procures ThyroSeq testing services, which are genetic assays essential for the precise molecular analysis of thyroid nodules, improving diagnostic accuracy in thyroid disease evaluation. This testing is critical for enhancing patient care in the healthcare sector through better-informed clinical decisions. The scope involves delivering specialized ThyroSeq molecular tests for a designated period, continuing services initially established under a substantial multi-year blanket purchase agreement. The BPA vehicle enables flexible orders throughout the contract duration. Awarded recently and executed on a non-competitive basis associated with the underlying BPA, this specific call supports ongoing readiness and continuity in crucial molecular diagnostic services. The latest performance period is set for one year, reflecting continued partnership and service provision in the molecular diagnostics domain.
Description
THYROSEQ TESTING - WHITE RIVER JUNCTION